Class action claims against Teladoc Health involve multiple consent violations across the company’s telehealth platforms, with the most prominent being allegations of unauthorized enrollment into paid subscriptions and unauthorized sharing of personal health data with third-party companies like Facebook. These lawsuits—including a July 2024 case filed in the Southern District of New York alleging robocalls marketing telehealth subscriptions without consent, and earlier cases like Taylor v.
Teladoc alleging that Teladoc installed Facebook Pixel tracking technology on its website to surreptitiously transmit users’ private communications and health information to Facebook—represent a pattern of consumer protection violations that have exposed millions of telehealth users to unwanted charges and unauthorized data collection. The core issue is that Teladoc and its subsidiaries enrolled users in paid annual plans and shared sensitive personal health information without obtaining clear, explicit consent.
Table of Contents
- What Are the Main Allegations Against Teladoc for Unauthorized Enrollment?
- How Does Unauthorized Data Sharing Compound the Problem?
- What About Teladoc’s Subsidiary BetterHelp and the FTC Enforcement Action?
- What Are Your Options If You Were Enrolled Without Consent or Your Data Was Shared?
- What Are the Common Warning Signs of Unauthorized Telehealth Enrollment?
- What Are the Broader Implications for Telehealth Privacy and Consent?
- What’s the Future of Teladoc Accountability and Telehealth Regulation?
What Are the Main Allegations Against Teladoc for Unauthorized Enrollment?
The central claim in the Teladoc robocalls case filed in July 2024 is that Teladoc hired a third-party marketing company, Health Insurance Innovations, to make unsolicited telephone calls to consumers selling telehealth subscriptions without obtaining their consent. According to court filings, these calls violated the Telephone Consumer Protection Act (TCPA), which prohibits companies from making automated or pre-recorded telemarketing calls to cell phones without prior express written consent.
Affected consumers reported being charged for annual subscriptions they never knowingly agreed to, only discovering the charges when they appeared on their bank statements or credit cards. What makes this pattern particularly problematic is that users who did sign up for a trial or free telehealth service—perhaps through a quick online form or mobile app—may have later been automatically transitioned into paid annual plans without clear notice or the opportunity to opt out. The lawsuit, brought by named plaintiffs April Hale and Len Cline, alleges that Teladoc failed to obtain explicit consent before enrolling these consumers, a violation that falls under both TCPA regulations and general consumer protection statutes.
How Does Unauthorized Data Sharing Compound the Problem?
Beyond the enrollment violations, Teladoc faces serious allegations of unauthorized data sharing that make the company’s consent practices even more concerning. In the case Taylor v. Teladoc (Case No. 7:24-cv-00664), plaintiffs allege that Teladoc installed facebook pixel tracking technology on its website without users’ knowledge, allowing Teladoc to send Facebook sensitive personal health information that users had provided during the telehealth signup process.
This means that when a user entered medical history, symptoms, prescriptions, or other private health details on Teladoc’s site, that information was automatically transmitted to Facebook’s servers—not just for site analytics, but potentially for Facebook’s own marketing and data collection purposes. However, Facebook Pixel itself is a common web analytics tool, and many websites use it. What made Teladoc’s use problematic was the transmission of health information—a category of data protected under HIPAA and other privacy laws—without users’ knowledge or consent. Users who filled out a telehealth questionnaire expecting only Teladoc to see their health history were shocked to discover that Facebook also received this sensitive data, which could be used for targeted advertising or other purposes entirely unrelated to their healthcare.
What About Teladoc’s Subsidiary BetterHelp and the FTC Enforcement Action?
The consent and data-sharing problems extend beyond Teladoc’s core telehealth platform to its mental health subsidiary, BetterHelp. In 2023, the Federal Trade Commission (FTC) fined BetterHelp $7.8 million for sharing consumer data with third parties—including Facebook and Snapchat—without obtaining proper consumer consent. Like the Facebook Pixel allegations in the main Teladoc case, BetterHelp’s violation involved transmitting sensitive personal information, including mental health data, to outside companies for purposes unrelated to providing therapy.
This subsidiary’s issues highlight how Teladoc’s consent problems are systemic rather than isolated to a single platform or marketing practice. Consumers using BetterHelp for therapy believed they were accessing a private mental health service, only to learn that their data—potentially including information about depression, anxiety, substance abuse, or other sensitive conditions—had been shared with social media companies. The FTC action demonstrates that regulatory bodies are taking these violations seriously, and it foreshadows potential penalties that Teladoc itself may face through the ongoing class actions.
What Are Your Options If You Were Enrolled Without Consent or Your Data Was Shared?
If you were charged for a Teladoc subscription you didn’t authorize, your first step is to contact your bank or credit card company to report the unauthorized charge and request a chargeback. Most financial institutions have a 60-120 day window for disputing fraudulent charges, so acting quickly is important. Document the charge, any communications with Teladoc, and any evidence that you did not consent to the subscription. You should also contact Teladoc directly to demand a full refund and request that your account be closed; keep a record of this communication.
Beyond seeking individual refunds, you may be eligible to join one of the class action lawsuits against Teladoc. Class actions allow consumers to collectively sue for damages and hold companies accountable for widespread practices. If you were enrolled without consent between certain dates, received robocalls from Health Insurance Innovations promoting Teladoc subscriptions, or had your health data transmitted to Facebook or other companies without your knowledge, you likely qualify as a class member. You can monitor official Teladoc settlement websites and legal firm announcements for claim filing deadlines; these deadlines are typically 60-90 days after a settlement is reached, so staying informed is critical.
What Are the Common Warning Signs of Unauthorized Telehealth Enrollment?
Several red flags should alert you to potential unauthorized charges or enrollment. If you see a recurring charge from Teladoc, BetterHelp, or related companies on your billing statement that you don’t recall authorizing, investigate immediately. Many unauthorized enrollments begin with a free trial or limited-time offer that users forget they started and then automatically converts to a paid subscription without a clear reminder email or opt-in confirmation. Receiving marketing calls from unfamiliar numbers claiming to offer Teladoc services is another warning sign—legitimate telehealth companies don’t typically use unsolicited robocalls to enroll patients.
Another warning sign is finding that your health information appears in targeted advertisements on Facebook, Instagram, or other platforms shortly after using a telehealth service. While this can be coincidental, it may indicate that your health data has been shared with advertisers. If you notice ads for psychiatric medications, anxiety treatments, or other health-related products appearing immediately after you signed up for telehealth, this pattern warrants investigation. Additionally, if you provided health information to Teladoc but received no HIPAA privacy notice or only a vague privacy policy, this suggests the company may not have proper data protection safeguards in place.
What Are the Broader Implications for Telehealth Privacy and Consent?
The Teladoc cases underscore a critical issue in the telehealth industry: the tension between business models that rely on aggressive marketing and growth, and consumers’ reasonable expectations of privacy and consent when sharing sensitive health information. Teladoc’s use of third-party marketing companies, automatic plan conversions, and data-sharing partnerships reflect practices that prioritize company revenue over user protection.
These lawsuits serve as a warning that regulators and courts are increasingly willing to penalize companies that treat health data as a commodity to be monetized rather than as sensitive personal information requiring explicit protection. Other telehealth platforms and digital health companies are watching these cases closely, knowing that similar practices could expose them to liability. Consumers should be cautious when signing up for any telehealth service, reading privacy policies carefully, opting out of marketing communications, and frequently checking billing statements for unexpected charges.
What’s the Future of Teladoc Accountability and Telehealth Regulation?
As these lawsuits progress through 2024 and into 2026, Teladoc faces potential settlements and judgments that could require significant payouts to affected users and stricter operational changes. The company may be required to implement clearer consent mechanisms, obtain explicit opt-in confirmations before charging for subscriptions, prohibit automatic plan conversions, and strengthen data protection practices.
The FTC’s enforcement action against BetterHelp already signals that regulators are prepared to use substantial fines to deter similar behavior across the industry. Looking forward, these cases may drive broader regulatory reforms for telehealth platforms, including stricter requirements for informed consent before enrollment, enhanced data protection rules, and clearer restrictions on sharing health information with marketing and advertising companies. The outcomes of the Teladoc litigation could set standards that the entire telehealth industry must follow, benefiting consumers through stronger privacy protections and more transparent billing practices.